Anti-inflammatory drugs may prevent the spread of breast cancer after surgery

a study by the Massachusetts Institute of Technology in the United States, nonsteroidal anti-inflammatory drugs (NSAIDS) may prevent the recurrence of cancer metastasis after breast cancer surgery. These drugs include aspirin, ibuprofen, and mobico.
researchers injected cancer cells into mice and then performed a mastectomy that mimicked what breast cancer patients received, and found that the size and number of tumors increased dramatically even when the location of the surgery was not near the cancer cell injection point. The researchers believe that the immune system could have inhibited the growth of cancer cells, a mechanism that is undermined by surgical trauma. After surgery, the immune system causes cells to move to new positions and divide, and also causes blood vessels to grow in order to heal the wound, causing cancer metastasis to return.
after concluding that it was the wound healing process, not the surgery itself that caused the cancer cells to spread, the researchers used Moby to try to stop the wound healing from causing the cancer cells to spread, with good results. After using the drug, cancer cells in mice decreased or even disappeared, and wound healing was not affected.
researchers reported the findings in
American Journal of Medicine on Monday. "Surgery is an essential tool for treating many tumors, especially breast cancer," said Jordan Klar, the report's first author. But any treatment can have side effects, and so can surgery. We are beginning to understand one of those potential side effects, which can help to find a supported treatment that works with surgery and may reduce side effects. Previous
previous studies have shown that 12 to 18 months after breast cancer surgery is the peak time for cancer metastasis, but it is not clear what mechanisms are behind this phenomenon. Many scholars therefore believe that this is the natural process of the development of the disease. (Source: Xinhua News Agency)